Showing results (1-10 of 245) with videos related to
Sort By:
Pageof 25
Genes|August 6, 2021
Understanding BRCA2 Function as a Tumor Suppressor Based on Domain-Specific Activities in DNA Damage ResponsesPaul R Andreassen, Joonbae Seo, Constanze Wiek, et al.Current Gene Therapy|January 10, 2017
Stem Cell Genetic Therapy for Fanconi Anemia - A New HopeHelmut Hanenberg, Katharina Roellecke, Constanze WiekAtlas of Genetics and Cytogenetics in Oncology and Haematology|July 6, 2019
XRCC2 (X-ray repair cross complementing 2)Paul R Andreassen, Helmut HanenbergAtlas of Genetics and Cytogenetics in Oncology and Haematology|August 16, 2019
PALB2 (partner and localizer of BRCA2)Helmut Hanenberg, Paul R AndreassenMolecular Pharmacology|July 10, 2012
CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of ω-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variantMariko Nakano, Edward J Kelly, Constanze Wiek, et al.Frontiers in Immunology|February 15, 2021
HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for "Off-the-Shelf" ImmunotherapyKeven Hoerster, Markus Uhrberg, Constanze Wiek, et al.Human Molecular Genetics|July 29, 2022
Identification of new RAD51D-regulating microRNAs that also emerge as potent inhibitors of the Fanconi anemia/homologous recombination pathwaysNina Hater, Katharina M Iwaniuk, Carina Leifeld, et al.Journal of Medical Genetics|May 22, 2016
Complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrates that XRCC2 is a Fanconi anaemia geneJung-Young Park, Elizabeth L Virts, Anna Jankowska, et al.Journal of Medicinal Chemistry|April 18, 2020
Design and Characterization of the First Selective and Potent Mechanism-Based Inhibitor of Cytochrome P450 4Z1John P Kowalski, Matthew G McDonald, Robert D Pelletier, et al.International Journal of Molecular Sciences|February 11, 2023
Spotlight on CYP4B1Annika Röder, Saskia Hüsken, Michael C Hutter, et al.Pageof 25